The UK-based Animalcare Grou p says its total revenue for the first half of the financial year ending December 31 was approximately 10% lower than in the comparable period in 2010. One of the reasons for this was the impact of temporary supply problems for its post-operative analgesia product ...

Novartis Animal Health has announced that it is restarting the distribution of stockpiled veterinary products from the US plant that was voluntarily closed last month (Animal Pharm January 20th). There is no schedule for the resumption of manufacture, although the company says this is a top ...

The voluntary closure of a Novartis manufacturing plant in the US over packaging problems with a line of human health pharmaceuticals is also affecting the production of certain animal health products for North America, particularly the Interceptor and Sentinel companion animal parasite ...

The North African country Libya has informed the World Organization for Animal Health (OIE) that multiple outbreaks of foot-and-mouth disease (FMD) have surfaced in cattle and sheep within the national boundaries. The FMD outbreaks have been reported in the northwest of the country, according to a ...

The confirmed presence of the Schmallenberg virus in five European countries has led to an urgent request from the European Commission for a risk assessment. The European Food Safety Authority (EFSA) is to advise how the virus could manifest itself in animals over the coming months. Virus experts ...

The UK-based Animalcare Grou p says its total revenue for the first half of the financial year ending December 31 was approximately 10% lower than in the comparable period in 2010. One of the reasons for this was the impact of temporary supply problems for its post-operative analgesia product ...

The Spanish Divasa-Farmavic (DFV) Group has made a significant investment in expanding its capacity to produce veterinary pharmaceuticals in Europe. These will be made both under its own brands and through contract manufacturing arrangements. The expansion is part of the company’s 2008-12 strategic ...

A study by the Irish farm institute Teagasc has revealed that there are no adverse effects in pigs being fed with genetically modified (GM) maize. Teagasc said the three-year study was conducted using GM maize sourced from Spain. It is a Bt-maize bred variety known for its insect resistant ...

Elanco Animal Health is to acquire a feed enzyme business in a move that is in line with its strategy to become involved in wider aspects of the food animal production chain. The business, a division of Eli Lilly and Company , has agreed to acquire the ChemGen Corporation, a privately owned held ...

A study by the Irish farm institute Teagasc has revealed that there are no adverse effects in pigs being fed with genetically modified (GM) maize. Teagasc said the three-year study was conducted using GM maize sourced from Spain. It is a Bt-maize bred variety known for its insect resistant ...

Elanco Animal Health is to acquire a feed enzyme business in a move that is in line with its strategy to become involved in wider aspects of the food animal production chain. The business, a division of Eli Lilly and Company , has agreed to acquire the ChemGen Corporation, a privately owned held ...

The veterinary product distributor Henry Schein has acquired a leading provider of surgical instruments and implants in the UK. The company has bought Sheffield-based Veterinary Instrumentation for an undisclosed sum. Veterinary Instrumentation, which employs 20 people, reported revenues of £6.7 ...

Pfizer has announced a proposal to exit the Synbiotics plant in Lyon, France, and consolidate the manufacturing operations of its veterinary diagnostics subsidiary into the Synbiotics facility at San Diego, California. Pfizer plans to exit the Lyon plant over the next 30 months and to transfer ...